COLUMN GROUP III-A, LP
CIK 1668085 · last filed 2026-01-15
COLUMN GROUP III-A, LP is a corporate insider who has filed 17 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing, for TNYA, was dated Feb 25, 2026. Across all open-market trades the lifetime net is +$199.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.68B across reported positions. The firm reports its address in San Francisco, CA. 77 SEC filings were submitted jointly with COLUMN GROUP III, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.68B
4
17
$199.83M
Filer Profile
SUITE 500
SAN FRANCISCO, CA 94158
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRZNW | 10%+ Owner | 996,502 | $0.00 | $1.5K | $2.50M | 1 | 2026-01-15 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 11,203,333 | $1.54 | $17.25M | $47.33M | 10 | 2023-01-17 |
| TNYA | 10%+ Owner | 4,414,720 | $0.68 | $3.02M | $150.00M | 1 | 2022-11-23 |
| RVMD | 10%+ Owner | 7,977,384 | $210.02 | $1.68B | $0 | 1 | 2020-02-18 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-25 | TNYA | Notice (144) | −1,060,727 | -$596.6K | EDGAR |
| 2026-02-20 | TNYA | Notice (144) | −1,591,090 | -$985.4K | EDGAR |
| 2026-02-11 | TNYA | Notice (144) | −742,663 | -$504.8K | EDGAR |
| 2026-02-10 | TNYA | Notice (144) | −1,591,090 | -$1.26M | EDGAR |
| 2026-01-15 | SRZNW | Buy (P) | +125,951 | $2.50M | EDGAR |
| 2023-01-17 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +53,780 | $266.0K | EDGAR |
| 2022-11-23 | TNYA | Buy (P) | +57,692,304 | $150.00M | EDGAR |
| 2022-06-02 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +1,230,448 | $16.56M | EDGAR |
| 2022-05-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +317,600 | $4.24M | EDGAR |
| 2020-08-03 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +4,392 | $79.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.